

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte proliferation (GO:0043616) | 6.76370334 |
| 2 | regulation of pigment cell differentiation (GO:0050932) | 6.41086568 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.98151884 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80385534 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.65926791 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.53798139 |
| 7 | vocalization behavior (GO:0071625) | 5.53315576 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.45070068 |
| 9 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 5.36542440 |
| 10 | glutamate secretion (GO:0014047) | 5.36257654 |
| 11 | positive regulation of developmental pigmentation (GO:0048087) | 5.31250725 |
| 12 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.30299824 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.28272644 |
| 14 | synaptic vesicle maturation (GO:0016188) | 5.17777491 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.05041442 |
| 16 | protein localization to synapse (GO:0035418) | 4.98172764 |
| 17 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.97662515 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.94441165 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.84280133 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.80420151 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.65781485 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.63773170 |
| 23 | response to insecticide (GO:0017085) | 4.59055679 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.54459404 |
| 25 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 4.40651765 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.33054577 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.29021148 |
| 28 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.27672328 |
| 29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.25818411 |
| 30 | presynaptic membrane assembly (GO:0097105) | 4.23993435 |
| 31 | postsynaptic membrane organization (GO:0001941) | 4.23760112 |
| 32 | nuclear pore complex assembly (GO:0051292) | 4.22915475 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 4.10521029 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 4.08861648 |
| 35 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.08560950 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.08427304 |
| 37 | establishment of integrated proviral latency (GO:0075713) | 4.08060710 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.00074887 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.99741542 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.94355148 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.92320896 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91509436 |
| 43 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.88954764 |
| 44 | presynaptic membrane organization (GO:0097090) | 3.86480788 |
| 45 | response to methylmercury (GO:0051597) | 3.81633462 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.77984970 |
| 47 | exploration behavior (GO:0035640) | 3.76800620 |
| 48 | auditory behavior (GO:0031223) | 3.73335749 |
| 49 | response to lead ion (GO:0010288) | 3.73224466 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.72221815 |
| 51 | mammary gland epithelial cell proliferation (GO:0033598) | 3.68567516 |
| 52 | positive regulation of neurotransmitter transport (GO:0051590) | 3.67980005 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.65043971 |
| 54 | activation of protein kinase A activity (GO:0034199) | 3.62126473 |
| 55 | nuclear pore organization (GO:0006999) | 3.61706788 |
| 56 | long-term synaptic potentiation (GO:0060291) | 3.60887649 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.59878258 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.59438043 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57325381 |
| 60 | skin morphogenesis (GO:0043589) | 3.55479824 |
| 61 | layer formation in cerebral cortex (GO:0021819) | 3.52803432 |
| 62 | glial cell proliferation (GO:0014009) | 3.52515638 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 3.51742863 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.50896563 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.49523950 |
| 66 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.48367671 |
| 67 | mechanosensory behavior (GO:0007638) | 3.48033793 |
| 68 | response to histamine (GO:0034776) | 3.43536129 |
| 69 | neurotransmitter transport (GO:0006836) | 3.41869432 |
| 70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.41477924 |
| 71 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.37192090 |
| 72 | cerebellar granule cell differentiation (GO:0021707) | 3.35700982 |
| 73 | neuron recognition (GO:0008038) | 3.34013957 |
| 74 | long-term memory (GO:0007616) | 3.32984360 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.32604112 |
| 76 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.31899402 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.31659378 |
| 78 | dendritic spine morphogenesis (GO:0060997) | 3.30792681 |
| 79 | proline transport (GO:0015824) | 3.29847299 |
| 80 | response to auditory stimulus (GO:0010996) | 3.28760224 |
| 81 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.25738307 |
| 82 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.25033927 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 3.25031780 |
| 84 | behavioral response to cocaine (GO:0048148) | 3.25023605 |
| 85 | membrane depolarization (GO:0051899) | 3.24746200 |
| 86 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23183464 |
| 87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.23027759 |
| 88 | positive regulation of Ras protein signal transduction (GO:0046579) | 3.22580455 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22236952 |
| 90 | axonal fasciculation (GO:0007413) | 3.20975520 |
| 91 | hypotonic response (GO:0006971) | 3.20712841 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.19923590 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 3.19893013 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 3.18459202 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15117529 |
| 96 | membrane hyperpolarization (GO:0060081) | 3.13542804 |
| 97 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12683635 |
| 98 | negative regulation of dendrite development (GO:2000171) | 3.12102953 |
| 99 | lung vasculature development (GO:0060426) | 3.11869853 |
| 100 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.11711220 |
| 101 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.10514570 |
| 102 | positive regulation of synaptic transmission (GO:0050806) | 3.10339394 |
| 103 | synaptic vesicle endocytosis (GO:0048488) | 3.08490123 |
| 104 | regulation of glutamate secretion (GO:0014048) | 3.08347232 |
| 105 | regulation of vesicle fusion (GO:0031338) | 3.07738550 |
| 106 | ribosome assembly (GO:0042255) | 3.07219765 |
| 107 | sensory perception of smell (GO:0007608) | 3.05916921 |
| 108 | regulation of dendritic spine development (GO:0060998) | 3.03461210 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02825391 |
| 110 | startle response (GO:0001964) | 3.01444922 |
| 111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00944868 |
| 112 | righting reflex (GO:0060013) | 2.99674783 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.99486868 |
| 114 | mitotic sister chromatid cohesion (GO:0007064) | 2.98162122 |
| 115 | pore complex assembly (GO:0046931) | 2.97790983 |
| 116 | synaptic transmission (GO:0007268) | 2.97670415 |
| 117 | calcium ion-dependent exocytosis (GO:0017156) | 2.97649681 |
| 118 | regulation of synapse maturation (GO:0090128) | 2.97376072 |
| 119 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.96665294 |
| 120 | positive regulation of small GTPase mediated signal transduction (GO:0051057) | 2.96029066 |
| 121 | prepulse inhibition (GO:0060134) | 2.95794397 |
| 122 | regulation of protein kinase A signaling (GO:0010738) | 2.94358196 |
| 123 | neuromuscular process controlling balance (GO:0050885) | 2.94299597 |
| 124 | regulation of synaptic transmission (GO:0050804) | 2.93143968 |
| 125 | striatum development (GO:0021756) | 2.92779134 |
| 126 | learning (GO:0007612) | 2.92460662 |
| 127 | transmission of nerve impulse (GO:0019226) | 2.91502605 |
| 128 | establishment of viral latency (GO:0019043) | 2.91228467 |
| 129 | synapse assembly (GO:0007416) | 2.90690222 |
| 130 | positive regulation of actin filament depolymerization (GO:0030836) | 2.90160318 |
| 131 | intraspecies interaction between organisms (GO:0051703) | 2.89692453 |
| 132 | social behavior (GO:0035176) | 2.89692453 |
| 133 | vesicle transport along microtubule (GO:0047496) | 2.89456726 |
| 134 | behavioral defense response (GO:0002209) | 2.89190964 |
| 135 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.87599096 |
| 136 | regulation of protein export from nucleus (GO:0046825) | 2.86249878 |
| 137 | replicative senescence (GO:0090399) | 2.84765191 |
| 138 | positive regulation of vesicle fusion (GO:0031340) | 2.84255834 |
| 139 | ribonucleoprotein complex disassembly (GO:0032988) | 2.82706710 |
| 140 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.77499345 |
| 141 | positive regulation of cell size (GO:0045793) | 2.76578277 |
| 142 | chaperone-mediated protein complex assembly (GO:0051131) | 2.74792108 |
| 143 | negative regulation of DNA repair (GO:0045738) | 2.72695187 |
| 144 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72652333 |
| 145 | negative regulation of receptor activity (GO:2000272) | 2.71373177 |
| 146 | regulation of cell communication by electrical coupling (GO:0010649) | 2.70244477 |
| 147 | cell adhesion mediated by integrin (GO:0033627) | 2.65175100 |
| 148 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65119113 |
| 149 | protein localization to microtubule (GO:0035372) | 2.64545323 |
| 150 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.64457657 |
| 151 | regulation of Rac protein signal transduction (GO:0035020) | 2.60939270 |
| 152 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.59928131 |
| 153 | activation of Rac GTPase activity (GO:0032863) | 2.57810597 |
| 154 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.57031400 |
| 155 | regulation of growth hormone secretion (GO:0060123) | 2.56741753 |
| 156 | regulation of mitotic spindle organization (GO:0060236) | 2.56670496 |
| 157 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.56124741 |
| 158 | positive regulation of potassium ion transport (GO:0043268) | 2.55538505 |
| 159 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55267600 |
| 160 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.55063065 |
| 161 | plasma membrane repair (GO:0001778) | 2.50030861 |
| 162 | mRNA transcription (GO:0009299) | 2.49036247 |
| 163 | positive regulation of DNA replication (GO:0045740) | 2.47655454 |
| 164 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.46246246 |
| 165 | mammary gland alveolus development (GO:0060749) | 2.44784390 |
| 166 | cellular senescence (GO:0090398) | 2.42416170 |
| 167 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.41674024 |
| 168 | membrane assembly (GO:0071709) | 2.39976672 |
| 169 | regulation of developmental pigmentation (GO:0048070) | 2.39877954 |
| 170 | response to arsenic-containing substance (GO:0046685) | 2.39283185 |
| 171 | bone remodeling (GO:0046849) | 2.38319633 |
| 172 | notochord development (GO:0030903) | 2.36558864 |
| 173 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.36123306 |
| 174 | non-recombinational repair (GO:0000726) | 2.35600049 |
| 175 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.35600049 |
| 176 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.35166193 |
| 177 | NLS-bearing protein import into nucleus (GO:0006607) | 2.34821518 |
| 178 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.32791092 |
| 179 | positive regulation of cytokinesis (GO:0032467) | 2.32401618 |
| 180 | regulation of pseudopodium assembly (GO:0031272) | 2.32230262 |
| 181 | cell communication involved in cardiac conduction (GO:0086065) | 2.31625950 |
| 182 | organelle transport along microtubule (GO:0072384) | 2.31131273 |
| 183 | organelle disassembly (GO:1903008) | 2.30134243 |
| 184 | barbed-end actin filament capping (GO:0051016) | 2.29791255 |
| 185 | positive regulation of pseudopodium assembly (GO:0031274) | 2.29291987 |
| 186 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.28717517 |
| 187 | morphogenesis of an epithelial sheet (GO:0002011) | 2.27852541 |
| 188 | membrane docking (GO:0022406) | 2.27127369 |
| 189 | myotube differentiation (GO:0014902) | 2.24896631 |
| 190 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.24451162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.96754787 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.29928808 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.14279065 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.09941935 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11271828 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02362665 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93632712 |
| 8 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.72591938 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.70477009 |
| 10 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 2.62898052 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62595228 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62595228 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58755399 |
| 14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57755915 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.56757788 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56116489 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49706535 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45953455 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45463639 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.41277148 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40809622 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39035326 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38130216 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.37338772 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24878151 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23364428 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21781227 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21688256 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.19631127 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13168560 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11975405 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10769578 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10278280 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04991130 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97796001 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94550681 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91027277 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90432873 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83335506 |
| 40 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.82862149 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80892174 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79440906 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77767241 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76740845 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74189818 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74139270 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.73432010 |
| 48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.73432010 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72628205 |
| 50 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.72232135 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71329129 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69989894 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.66675037 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64896994 |
| 55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64896994 |
| 56 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.61363502 |
| 57 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.58137226 |
| 58 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.57540170 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.52100750 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49976098 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49587608 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48009370 |
| 63 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.47999950 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46770431 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45087838 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45066933 |
| 67 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.43904110 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43221825 |
| 69 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.42159004 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41707712 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41599533 |
| 72 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.41324218 |
| 73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40138511 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40069622 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40003825 |
| 76 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.39308725 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38839753 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37066042 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37033468 |
| 80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36321552 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36054750 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35924858 |
| 83 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34951754 |
| 84 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34020372 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.33343229 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33192263 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32610968 |
| 88 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32361472 |
| 89 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31906087 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30564504 |
| 91 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28782996 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28536562 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27460412 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27409059 |
| 95 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26334509 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26156519 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25465995 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25075329 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24194132 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23734092 |
| 101 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23639722 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23581648 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22090870 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21391671 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19962699 |
| 106 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18611729 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18346834 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17519355 |
| 109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17443405 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 1.17359342 |
| 111 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15329676 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15142564 |
| 113 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.14615943 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11746854 |
| 115 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10132312 |
| 116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09802945 |
| 117 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09449951 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08594469 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07307947 |
| 120 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06865161 |
| 121 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06073545 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05737976 |
| 123 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05485652 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05222046 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04738472 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04049816 |
| 127 | * POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 1.03939565 |
| 128 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03221814 |
| 129 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02886952 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02711839 |
| 131 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01804278 |
| 132 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01695671 |
| 133 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00321080 |
| 134 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99700640 |
| 135 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99642371 |
| 136 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99506354 |
| 137 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99464132 |
| 138 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98793405 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98641007 |
| 140 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97598052 |
| 141 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97529098 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97135566 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96601132 |
| 144 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96384996 |
| 145 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.95013016 |
| 146 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94616572 |
| 147 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94552506 |
| 148 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94533628 |
| 149 | JUN_21703547_ChIP-Seq_K562_Human | 0.94401980 |
| 150 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94280745 |
| 151 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.94011321 |
| 152 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93932333 |
| 153 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93919057 |
| 154 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93323377 |
| 155 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92782470 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92221523 |
| 157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92155022 |
| 158 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92145666 |
| 159 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92027446 |
| 160 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91738549 |
| 161 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91659752 |
| 162 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91164229 |
| 163 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90534465 |
| 164 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90510236 |
| 165 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89918484 |
| 166 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89814281 |
| 167 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87671401 |
| 168 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87671401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.79249240 |
| 2 | MP0003880_abnormal_central_pattern | 5.50348017 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.03658991 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.66470619 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 3.64210681 |
| 6 | MP0004270_analgesia | 3.55807711 |
| 7 | MP0009745_abnormal_behavioral_response | 3.40998322 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 3.33036423 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.29373414 |
| 10 | MP0009046_muscle_twitch | 3.15650437 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.15371778 |
| 12 | MP0002064_seizures | 3.11518470 |
| 13 | MP0002822_catalepsy | 3.04688649 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.80982405 |
| 15 | MP0009697_abnormal_copulation | 2.77506604 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55756557 |
| 17 | MP0002272_abnormal_nervous_system | 2.55156971 |
| 18 | MP0002736_abnormal_nociception_after | 2.47578403 |
| 19 | MP0001486_abnormal_startle_reflex | 2.43173617 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.30613503 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.25991151 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.22802260 |
| 23 | MP0008057_abnormal_DNA_replication | 2.22222680 |
| 24 | MP0001984_abnormal_olfaction | 2.13906985 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.11480243 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.10295682 |
| 27 | MP0002067_abnormal_sensory_capabilities | 2.06435602 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.98571423 |
| 29 | MP0000751_myopathy | 1.97039483 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.88971038 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.87299898 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.86469542 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.84629865 |
| 34 | MP0001970_abnormal_pain_threshold | 1.84499757 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.82677866 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.80548657 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.80402326 |
| 38 | MP0004924_abnormal_behavior | 1.79962590 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.79962590 |
| 40 | MP0008569_lethality_at_weaning | 1.78612538 |
| 41 | MP0002009_preneoplasia | 1.77677077 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.76580463 |
| 43 | MP0003879_abnormal_hair_cell | 1.74310577 |
| 44 | MP0002184_abnormal_innervation | 1.73254150 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.62268662 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.62235909 |
| 47 | MP0001529_abnormal_vocalization | 1.60343766 |
| 48 | MP0003787_abnormal_imprinting | 1.58653830 |
| 49 | MP0002234_abnormal_pharynx_morphology | 1.55153380 |
| 50 | MP0000778_abnormal_nervous_system | 1.53322831 |
| 51 | MP0002269_muscular_atrophy | 1.45336513 |
| 52 | MP0000762_abnormal_tongue_morphology | 1.45172797 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.44389226 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.44298044 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.42174249 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.38385824 |
| 57 | MP0003329_amyloid_beta_deposits | 1.37534263 |
| 58 | MP0004858_abnormal_nervous_system | 1.36051197 |
| 59 | MP0000733_abnormal_muscle_development | 1.34385914 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.34169795 |
| 61 | MP0005187_abnormal_penis_morphology | 1.34146019 |
| 62 | MP0001188_hyperpigmentation | 1.33323150 |
| 63 | MP0000955_abnormal_spinal_cord | 1.31632939 |
| 64 | MP0003633_abnormal_nervous_system | 1.30713330 |
| 65 | MP0003941_abnormal_skin_development | 1.29030354 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.28767748 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.27875650 |
| 68 | MP0002233_abnormal_nose_morphology | 1.27508987 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.27327010 |
| 70 | MP0003122_maternal_imprinting | 1.24270754 |
| 71 | MP0004197_abnormal_fetal_growth/weight/ | 1.19899116 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.19369551 |
| 73 | MP0010094_abnormal_chromosome_stability | 1.19235653 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 1.18068217 |
| 75 | MP0001905_abnormal_dopamine_level | 1.17663463 |
| 76 | MP0003385_abnormal_body_wall | 1.16373819 |
| 77 | MP0003077_abnormal_cell_cycle | 1.13897207 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.13502595 |
| 79 | MP0004215_abnormal_myocardial_fiber | 1.13150024 |
| 80 | MP0002971_abnormal_brown_adipose | 1.11355712 |
| 81 | MP0004087_abnormal_muscle_fiber | 1.07781202 |
| 82 | MP0004142_abnormal_muscle_tone | 1.07132594 |
| 83 | MP0001293_anophthalmia | 1.06805831 |
| 84 | MP0003646_muscle_fatigue | 1.06558327 |
| 85 | MP0010386_abnormal_urinary_bladder | 1.06558146 |
| 86 | MP0000537_abnormal_urethra_morphology | 1.04553528 |
| 87 | MP0003631_nervous_system_phenotype | 1.02081011 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.01198096 |
| 89 | MP0000427_abnormal_hair_cycle | 1.01158959 |
| 90 | MP0003091_abnormal_cell_migration | 1.00324531 |
| 91 | MP0002697_abnormal_eye_size | 0.99067234 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.98234868 |
| 93 | MP0004085_abnormal_heartbeat | 0.98191849 |
| 94 | MP0002152_abnormal_brain_morphology | 0.98173478 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.96277446 |
| 96 | MP0004484_altered_response_of | 0.96181436 |
| 97 | MP0004233_abnormal_muscle_weight | 0.95055462 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.93823390 |
| 99 | MP0001340_abnormal_eyelid_morphology | 0.93304584 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.93187457 |
| 101 | MP0000516_abnormal_urinary_system | 0.93187457 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.92914884 |
| 103 | MP0008874_decreased_physiological_sensi | 0.92038064 |
| 104 | MP0002092_abnormal_eye_morphology | 0.91431947 |
| 105 | MP0004885_abnormal_endolymph | 0.90478161 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.89567825 |
| 107 | MP0004742_abnormal_vestibular_system | 0.89269225 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.87981684 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.87358161 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.87020608 |
| 111 | MP0000383_abnormal_hair_follicle | 0.86391761 |
| 112 | MP0008872_abnormal_physiological_respon | 0.86126366 |
| 113 | MP0004272_abnormal_basement_membrane | 0.85047187 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.83239043 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.81910397 |
| 116 | MP0003828_pulmonary_edema | 0.81778369 |
| 117 | MP0003890_abnormal_embryonic-extraembry | 0.79010422 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.78681638 |
| 119 | MP0005535_abnormal_body_temperature | 0.78574830 |
| 120 | MP0002084_abnormal_developmental_patter | 0.78285087 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.77915939 |
| 122 | MP0008058_abnormal_DNA_repair | 0.76751718 |
| 123 | MP0001177_atelectasis | 0.76158966 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.76100773 |
| 125 | MP0002229_neurodegeneration | 0.76076782 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.75011086 |
| 127 | MP0002177_abnormal_outer_ear | 0.75002944 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.74782841 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.74461887 |
| 130 | MP0005499_abnormal_olfactory_system | 0.74461887 |
| 131 | MP0005409_darkened_coat_color | 0.73603315 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.73242798 |
| 133 | MP0000749_muscle_degeneration | 0.73056632 |
| 134 | MP0002970_abnormal_white_adipose | 0.72995606 |
| 135 | MP0003315_abnormal_perineum_morphology | 0.72756636 |
| 136 | MP0005330_cardiomyopathy | 0.72472876 |
| 137 | MP0004084_abnormal_cardiac_muscle | 0.71022708 |
| 138 | MP0009115_abnormal_fat_cell | 0.70493551 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.69592634 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.68269140 |
| 141 | MP0005501_abnormal_skin_physiology | 0.68264695 |
| 142 | MP0000747_muscle_weakness | 0.68253701 |
| 143 | MP0004130_abnormal_muscle_cell | 0.67854217 |
| 144 | MP0001697_abnormal_embryo_size | 0.67814274 |
| 145 | MP0008877_abnormal_DNA_methylation | 0.67704055 |
| 146 | MP0005171_absent_coat_pigmentation | 0.66743381 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.66697286 |
| 148 | MP0002752_abnormal_somatic_nervous | 0.65507245 |
| 149 | MP0001664_abnormal_digestion | 0.64192939 |
| 150 | MP0001943_abnormal_respiration | 0.63144438 |
| 151 | MP0002090_abnormal_vision | 0.62199150 |
| 152 | MP0003634_abnormal_glial_cell | 0.57561518 |
| 153 | MP0001299_abnormal_eye_distance/ | 0.56327996 |
| 154 | MP0002653_abnormal_ependyma_morphology | 0.55134089 |
| 155 | MP0003075_altered_response_to | 0.54988137 |
| 156 | MP0003183_abnormal_peptide_metabolism | 0.54753136 |
| 157 | MP0000759_abnormal_skeletal_muscle | 0.53290761 |
| 158 | MP0004510_myositis | 0.52493444 |
| 159 | MP0002106_abnormal_muscle_physiology | 0.51892740 |
| 160 | MP0002638_abnormal_pupillary_reflex | 0.51640777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.07645041 |
| 2 | Myokymia (HP:0002411) | 5.97060419 |
| 3 | Focal seizures (HP:0007359) | 5.68777413 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.47738255 |
| 5 | Atonic seizures (HP:0010819) | 5.19973762 |
| 6 | Febrile seizures (HP:0002373) | 4.68970487 |
| 7 | Insomnia (HP:0100785) | 4.44007215 |
| 8 | Visual hallucinations (HP:0002367) | 4.41858107 |
| 9 | Absence seizures (HP:0002121) | 4.33306537 |
| 10 | Hyperventilation (HP:0002883) | 4.24759150 |
| 11 | Broad-based gait (HP:0002136) | 4.09814841 |
| 12 | Dialeptic seizures (HP:0011146) | 3.99135958 |
| 13 | Subaortic stenosis (HP:0001682) | 3.88322234 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.88322234 |
| 15 | Diaphragmatic weakness (HP:0009113) | 3.85213027 |
| 16 | Progressive external ophthalmoplegia (HP:0000590) | 3.77038702 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.74913712 |
| 18 | Subacute progressive viral hepatitis (HP:0006572) | 3.64788643 |
| 19 | Bundle branch block (HP:0011710) | 3.62692889 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.61346303 |
| 21 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.45482737 |
| 22 | Nemaline bodies (HP:0003798) | 3.34373386 |
| 23 | Vertebral arch anomaly (HP:0008438) | 3.33933238 |
| 24 | Papillary thyroid carcinoma (HP:0002895) | 3.33817356 |
| 25 | Poor eye contact (HP:0000817) | 3.33649261 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.28374060 |
| 27 | Amblyopia (HP:0000646) | 3.23686822 |
| 28 | Muscle fiber inclusion bodies (HP:0100299) | 3.18968881 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.18362491 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.13192823 |
| 31 | Action tremor (HP:0002345) | 3.05104562 |
| 32 | Dysmetric saccades (HP:0000641) | 3.01158349 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.97757849 |
| 34 | Exercise-induced muscle cramps (HP:0003710) | 2.94393332 |
| 35 | Ankle clonus (HP:0011448) | 2.93516338 |
| 36 | Abnormal social behavior (HP:0012433) | 2.89662770 |
| 37 | Impaired social interactions (HP:0000735) | 2.89662770 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.89463268 |
| 39 | Depression (HP:0000716) | 2.88459173 |
| 40 | Truncal ataxia (HP:0002078) | 2.79031498 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.78543514 |
| 42 | Anxiety (HP:0000739) | 2.73067655 |
| 43 | Pheochromocytoma (HP:0002666) | 2.66057732 |
| 44 | Urinary urgency (HP:0000012) | 2.59469395 |
| 45 | Excessive salivation (HP:0003781) | 2.56724614 |
| 46 | Drooling (HP:0002307) | 2.56724614 |
| 47 | Impaired smooth pursuit (HP:0007772) | 2.51617733 |
| 48 | Termporal pattern (HP:0011008) | 2.51088980 |
| 49 | Insidious onset (HP:0003587) | 2.51088980 |
| 50 | Confusion (HP:0001289) | 2.51074652 |
| 51 | Exercise-induced myalgia (HP:0003738) | 2.48711620 |
| 52 | Epileptiform EEG discharges (HP:0011182) | 2.48632699 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.47510972 |
| 54 | Dysmetria (HP:0001310) | 2.45664078 |
| 55 | Delusions (HP:0000746) | 2.45601918 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.44319979 |
| 57 | Abnormality of the corticospinal tract (HP:0002492) | 2.44138715 |
| 58 | Limb dystonia (HP:0002451) | 2.44026615 |
| 59 | Protruding tongue (HP:0010808) | 2.43449505 |
| 60 | Stereotypic behavior (HP:0000733) | 2.43298793 |
| 61 | Torticollis (HP:0000473) | 2.43055467 |
| 62 | Cortical dysplasia (HP:0002539) | 2.38788419 |
| 63 | Genetic anticipation (HP:0003743) | 2.38662997 |
| 64 | Neuroendocrine neoplasm (HP:0100634) | 2.37971033 |
| 65 | Postural instability (HP:0002172) | 2.36002464 |
| 66 | Resting tremor (HP:0002322) | 2.34663909 |
| 67 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.34143310 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.34143310 |
| 69 | Progressive inability to walk (HP:0002505) | 2.33742877 |
| 70 | Microglossia (HP:0000171) | 2.32897701 |
| 71 | Papilledema (HP:0001085) | 2.32878521 |
| 72 | EMG: myopathic abnormalities (HP:0003458) | 2.31868748 |
| 73 | Shoulder girdle muscle weakness (HP:0003547) | 2.31224405 |
| 74 | Increased density of long bones (HP:0006392) | 2.29979794 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.27294996 |
| 76 | Inability to walk (HP:0002540) | 2.25025541 |
| 77 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.22742689 |
| 78 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.22742689 |
| 79 | Focal dystonia (HP:0004373) | 2.22699518 |
| 80 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21706919 |
| 81 | Impaired vibratory sensation (HP:0002495) | 2.19728417 |
| 82 | Polyphagia (HP:0002591) | 2.18784096 |
| 83 | Bradykinesia (HP:0002067) | 2.17454703 |
| 84 | Lower limb amyotrophy (HP:0007210) | 2.16912294 |
| 85 | Scanning speech (HP:0002168) | 2.16560988 |
| 86 | Hyporeflexia of lower limbs (HP:0002600) | 2.16445971 |
| 87 | Micronodular cirrhosis (HP:0001413) | 2.14628322 |
| 88 | Upper limb muscle weakness (HP:0003484) | 2.14319153 |
| 89 | Gait imbalance (HP:0002141) | 2.13614712 |
| 90 | Unilateral renal agenesis (HP:0000122) | 2.13252361 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.12212739 |
| 92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.09467597 |
| 93 | Hypoventilation (HP:0002791) | 2.09238012 |
| 94 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.08337536 |
| 95 | Short chin (HP:0000331) | 2.08065200 |
| 96 | Sensory axonal neuropathy (HP:0003390) | 2.06907573 |
| 97 | Absent speech (HP:0001344) | 2.06428436 |
| 98 | Spastic gait (HP:0002064) | 2.05622715 |
| 99 | Craniofacial dystonia (HP:0012179) | 2.05402516 |
| 100 | Failure to thrive in infancy (HP:0001531) | 2.05225955 |
| 101 | Curly hair (HP:0002212) | 2.04966615 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.04957619 |
| 103 | Hypsarrhythmia (HP:0002521) | 2.04454561 |
| 104 | Thyroid carcinoma (HP:0002890) | 2.04100106 |
| 105 | Lower limb muscle weakness (HP:0007340) | 2.03442770 |
| 106 | Incomplete penetrance (HP:0003829) | 2.02931403 |
| 107 | Volvulus (HP:0002580) | 2.01657527 |
| 108 | Myotonia (HP:0002486) | 2.00928237 |
| 109 | Mutism (HP:0002300) | 2.00615760 |
| 110 | Agitation (HP:0000713) | 2.00467794 |
| 111 | Menstrual irregularities (HP:0000858) | 2.00449554 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00102367 |
| 113 | Missing ribs (HP:0000921) | 1.98254772 |
| 114 | Atrioventricular block (HP:0001678) | 1.98014127 |
| 115 | Blue irides (HP:0000635) | 1.95333723 |
| 116 | Abnormal auditory evoked potentials (HP:0006958) | 1.95276699 |
| 117 | Hyperthyroidism (HP:0000836) | 1.94639385 |
| 118 | Abnormal hair whorl (HP:0010721) | 1.93161000 |
| 119 | Type 1 muscle fiber predominance (HP:0003803) | 1.93089475 |
| 120 | Specific learning disability (HP:0001328) | 1.91369560 |
| 121 | Status epilepticus (HP:0002133) | 1.91328726 |
| 122 | Pelvic girdle muscle weakness (HP:0003749) | 1.90085621 |
| 123 | Abnormality of the calf musculature (HP:0001430) | 1.88446042 |
| 124 | Ventricular fibrillation (HP:0001663) | 1.87578703 |
| 125 | Cystic hygroma (HP:0000476) | 1.83367644 |
| 126 | Abnormal EKG (HP:0003115) | 1.82896821 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.82819981 |
| 128 | Narrow nasal bridge (HP:0000446) | 1.82538324 |
| 129 | Congenital primary aphakia (HP:0007707) | 1.82460105 |
| 130 | Hemiparesis (HP:0001269) | 1.81394352 |
| 131 | Sudden death (HP:0001699) | 1.80609678 |
| 132 | Prolonged QT interval (HP:0001657) | 1.79212463 |
| 133 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78431946 |
| 134 | Diplopia (HP:0000651) | 1.77397065 |
| 135 | Abnormality of binocular vision (HP:0011514) | 1.77397065 |
| 136 | Annular pancreas (HP:0001734) | 1.77283370 |
| 137 | Scapular winging (HP:0003691) | 1.75475826 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.75026242 |
| 139 | Freckling (HP:0001480) | 1.73737062 |
| 140 | Neck muscle weakness (HP:0000467) | 1.73340709 |
| 141 | Hemiplegia (HP:0002301) | 1.73109584 |
| 142 | Chorioretinal atrophy (HP:0000533) | 1.72987258 |
| 143 | Inappropriate behavior (HP:0000719) | 1.71589867 |
| 144 | Poor suck (HP:0002033) | 1.69724610 |
| 145 | Abnormal atrioventricular conduction (HP:0005150) | 1.69140430 |
| 146 | Spastic paraplegia (HP:0001258) | 1.68851528 |
| 147 | Autoamputation (HP:0001218) | 1.68663213 |
| 148 | Nephrogenic diabetes insipidus (HP:0009806) | 1.68105294 |
| 149 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67941208 |
| 150 | Absent/shortened dynein arms (HP:0200106) | 1.67941208 |
| 151 | Increased connective tissue (HP:0009025) | 1.67792371 |
| 152 | Generalized hypotonia (HP:0001290) | 1.67684734 |
| 153 | Distal sensory impairment (HP:0002936) | 1.67348524 |
| 154 | Primitive neuroectodermal tumor (HP:0030065) | 1.67338616 |
| 155 | Neuroblastic tumors (HP:0004376) | 1.67338616 |
| 156 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.67338616 |
| 157 | Neuroblastoma (HP:0003006) | 1.67338616 |
| 158 | Large hands (HP:0001176) | 1.65968035 |
| 159 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.65545771 |
| 160 | Spinal rigidity (HP:0003306) | 1.63645816 |
| 161 | Amyotrophic lateral sclerosis (HP:0007354) | 1.63315330 |
| 162 | Hyponatremia (HP:0002902) | 1.59735680 |
| 163 | Neurofibrillary tangles (HP:0002185) | 1.58310122 |
| 164 | Entropion (HP:0000621) | 1.57912028 |
| 165 | Apathy (HP:0000741) | 1.57474117 |
| 166 | Absent eyebrow (HP:0002223) | 1.57465154 |
| 167 | Spastic tetraparesis (HP:0001285) | 1.57220780 |
| 168 | Long foot (HP:0001833) | 1.56445702 |
| 169 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.55162327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.05668805 |
| 2 | MST4 | 6.00648368 |
| 3 | EPHA4 | 4.42714852 |
| 4 | CASK | 4.36995073 |
| 5 | NTRK3 | 3.86331049 |
| 6 | STK39 | 3.39613289 |
| 7 | DAPK2 | 3.26174041 |
| 8 | MAP3K9 | 3.07527755 |
| 9 | MAP3K4 | 3.04196480 |
| 10 | EPHA2 | 2.94909741 |
| 11 | MET | 2.78597175 |
| 12 | MAP2K7 | 2.77714535 |
| 13 | CDK19 | 2.73286986 |
| 14 | MAP3K12 | 2.65545751 |
| 15 | TRIM28 | 2.64078380 |
| 16 | SCYL2 | 2.49814056 |
| 17 | MARK1 | 2.38567421 |
| 18 | PBK | 2.34519429 |
| 19 | MINK1 | 2.26572488 |
| 20 | DAPK1 | 2.20687173 |
| 21 | TSSK6 | 1.96640196 |
| 22 | MAP2K4 | 1.93350568 |
| 23 | WNK4 | 1.89829542 |
| 24 | PAK6 | 1.85899452 |
| 25 | NTRK2 | 1.83513314 |
| 26 | RIPK4 | 1.79918203 |
| 27 | STK38L | 1.76326092 |
| 28 | PLK2 | 1.75932023 |
| 29 | KSR2 | 1.73321195 |
| 30 | CCNB1 | 1.66044726 |
| 31 | KSR1 | 1.58527804 |
| 32 | ERBB4 | 1.58135931 |
| 33 | CAMKK1 | 1.55631975 |
| 34 | PRKD3 | 1.47445150 |
| 35 | BUB1 | 1.45880711 |
| 36 | CDK5 | 1.42062026 |
| 37 | BRD4 | 1.40785505 |
| 38 | STK10 | 1.39122179 |
| 39 | NTRK1 | 1.38939259 |
| 40 | LATS1 | 1.38419693 |
| 41 | PRPF4B | 1.36470196 |
| 42 | EIF2AK3 | 1.35366090 |
| 43 | CAMKK2 | 1.33836773 |
| 44 | MAPK13 | 1.30948990 |
| 45 | GRK5 | 1.28831054 |
| 46 | ARAF | 1.23602827 |
| 47 | PHKG2 | 1.23320418 |
| 48 | PHKG1 | 1.23320418 |
| 49 | AKT3 | 1.21937493 |
| 50 | OXSR1 | 1.20134459 |
| 51 | WEE1 | 1.18446663 |
| 52 | SGK2 | 1.17375383 |
| 53 | SGK494 | 1.15743683 |
| 54 | SGK223 | 1.15743683 |
| 55 | PRKCG | 1.11575837 |
| 56 | SIK2 | 1.09179815 |
| 57 | TAOK1 | 1.08204659 |
| 58 | CAMK2A | 1.04764150 |
| 59 | TNIK | 0.99015533 |
| 60 | SIK3 | 0.94382178 |
| 61 | STK38 | 0.92725618 |
| 62 | EIF2AK1 | 0.92144106 |
| 63 | CDK18 | 0.91130826 |
| 64 | NEK6 | 0.90937421 |
| 65 | FES | 0.88208512 |
| 66 | TTN | 0.86663625 |
| 67 | SGK3 | 0.85340416 |
| 68 | CDK15 | 0.84777332 |
| 69 | BMPR2 | 0.82162852 |
| 70 | CDK14 | 0.81756078 |
| 71 | PNCK | 0.81534278 |
| 72 | TYRO3 | 0.81123138 |
| 73 | UHMK1 | 0.81050325 |
| 74 | MAP3K2 | 0.80924296 |
| 75 | CAMK2B | 0.80108499 |
| 76 | PDGFRA | 0.79524766 |
| 77 | ICK | 0.79327654 |
| 78 | STK11 | 0.78999091 |
| 79 | PDK4 | 0.77282550 |
| 80 | PDK3 | 0.77282550 |
| 81 | EIF2AK2 | 0.76465129 |
| 82 | STK3 | 0.76013937 |
| 83 | RAF1 | 0.75862028 |
| 84 | PTK2B | 0.74213012 |
| 85 | CSNK1A1L | 0.74127796 |
| 86 | CDK11A | 0.73305750 |
| 87 | MUSK | 0.72466166 |
| 88 | MAP3K13 | 0.71059039 |
| 89 | LIMK1 | 0.68459742 |
| 90 | SGK1 | 0.68211285 |
| 91 | NEK1 | 0.68058228 |
| 92 | AKT2 | 0.67749056 |
| 93 | CAMK1 | 0.66239218 |
| 94 | PTK2 | 0.66152063 |
| 95 | SRPK1 | 0.65923545 |
| 96 | PAK3 | 0.64637328 |
| 97 | DAPK3 | 0.64539036 |
| 98 | PRKCH | 0.63612760 |
| 99 | WNK1 | 0.63131220 |
| 100 | SIK1 | 0.63005992 |
| 101 | TTK | 0.62667449 |
| 102 | BRSK1 | 0.62073654 |
| 103 | ERBB3 | 0.61235069 |
| 104 | LATS2 | 0.60042006 |
| 105 | DYRK1A | 0.56391464 |
| 106 | RPS6KA4 | 0.56247694 |
| 107 | RET | 0.55965182 |
| 108 | STK24 | 0.55204723 |
| 109 | PRKCE | 0.53890124 |
| 110 | MAP3K1 | 0.53739564 |
| 111 | BRSK2 | 0.53718792 |
| 112 | LMTK2 | 0.52092385 |
| 113 | NEK2 | 0.51550082 |
| 114 | PDK1 | 0.50873363 |
| 115 | PINK1 | 0.50706880 |
| 116 | BRAF | 0.49923761 |
| 117 | NME1 | 0.49548126 |
| 118 | CSNK1G2 | 0.49382400 |
| 119 | CAMK2D | 0.48891309 |
| 120 | MAPK12 | 0.48780615 |
| 121 | MAP2K1 | 0.48001451 |
| 122 | ROCK2 | 0.47525729 |
| 123 | MAP3K14 | 0.46042748 |
| 124 | CAMK4 | 0.45830882 |
| 125 | PDPK1 | 0.45196280 |
| 126 | CAMK2G | 0.44516546 |
| 127 | RPS6KA3 | 0.42766032 |
| 128 | TNK2 | 0.41205537 |
| 129 | PRKCI | 0.41125664 |
| 130 | FER | 0.40867835 |
| 131 | PAK4 | 0.40546247 |
| 132 | PDGFRB | 0.40538962 |
| 133 | MARK2 | 0.40508415 |
| 134 | RIPK1 | 0.40008764 |
| 135 | ADRBK1 | 0.38936057 |
| 136 | MAPK7 | 0.38935782 |
| 137 | BMX | 0.38345740 |
| 138 | BCR | 0.37256560 |
| 139 | YES1 | 0.37008862 |
| 140 | WNK3 | 0.35968129 |
| 141 | MAPK10 | 0.35225824 |
| 142 | MAP3K7 | 0.34937520 |
| 143 | MAP3K6 | 0.34646829 |
| 144 | PRKCZ | 0.33687501 |
| 145 | OBSCN | 0.33684388 |
| 146 | MOS | 0.33596465 |
| 147 | ROCK1 | 0.33206886 |
| 148 | JAK1 | 0.32548120 |
| 149 | PLK1 | 0.31693210 |
| 150 | TAF1 | 0.31415715 |
| 151 | MAP3K5 | 0.28887790 |
| 152 | MKNK2 | 0.28179204 |
| 153 | ALK | 0.27730525 |
| 154 | PLK3 | 0.27519327 |
| 155 | MELK | 0.27280961 |
| 156 | CDK6 | 0.25960652 |
| 157 | FGR | 0.25413564 |
| 158 | CSNK1D | 0.24790454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.69308266 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.56784717 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.15635810 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66090703 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64505678 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62482117 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.58797525 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.54206861 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50204132 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35427923 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.24662857 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19255618 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 2.11207294 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.03373533 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.02348036 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.97217806 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.91707180 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83417269 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83286582 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82363622 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.80874926 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75951992 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74468187 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72992586 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.72620833 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70901762 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.67959648 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66039303 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64923548 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.58967858 |
| 31 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.58479127 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56834245 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.51555862 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50963713 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43477515 |
| 36 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.42733599 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38211417 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36509206 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.34027808 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30713081 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30312669 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28100074 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25809833 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25691913 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24498220 |
| 46 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.24207446 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23870358 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21775001 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 1.20730605 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 1.14311769 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09191717 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08691605 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08006775 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07052697 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06591186 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04257774 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03487417 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.02757446 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01991675 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01659369 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.01144630 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97903752 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96286962 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.96084844 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.93740396 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93315108 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91160506 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.89987248 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.89691097 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88141470 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.87728863 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85382866 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81848630 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81015184 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80248670 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79383619 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78336955 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77376837 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76666378 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76659314 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76055880 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.74453444 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73866932 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71185468 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69539130 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68805944 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68234260 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68229747 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66063476 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65667035 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64766731 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63890979 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63815492 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63582788 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63520648 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.62531522 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61350435 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61068428 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.59870993 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59532988 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59174536 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58895535 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57498152 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.57134658 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54237316 |
| 106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53601655 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53338153 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52397824 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52016329 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50119320 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49753775 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49636072 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49408389 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48688413 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48580895 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48390631 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46582968 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46088114 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45896827 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45142799 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45098229 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44596158 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44270274 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43852768 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42707951 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41565628 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40348534 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.40341579 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40218341 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39860398 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38825347 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37572670 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36063704 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.35832672 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34776412 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30998502 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28845349 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28241065 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27518957 |

